Suppr超能文献

儿童相关性腹膜炎。

Dialysis-associated peritonitis in children.

机构信息

Department of Pediatrics, Section of Nephrology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.

出版信息

Pediatr Nephrol. 2010 Mar;25(3):425-40. doi: 10.1007/s00467-008-1113-6. Epub 2009 Feb 4.

Abstract

Peritonitis remains a frequent complication of peritoneal dialysis in children and is the most common reason for technique failure. The microbiology is characterized by a predominance of Gram-positive organisms, with fungi responsible for less than 5% of episodes. Data collected by the International Pediatric Peritonitis Registry have revealed a worldwide variation in the bacterial etiology of peritonitis, as well as in the rate of culture-negative peritonitis. Risk factors for infection include young age, the absence of prophylactic antibiotics at catheter placement, spiking of dialysis bags, and the presence of a catheter exit-site or tunnel infection. Clinical symptoms at presentation are somewhat organism specific and can be objectively assessed with a Disease Severity Score. Whereas recommendations for empiric antibiotic therapy in children have been published by the International Society of Peritoneal Dialysis, epidemiologic data and antibiotic susceptibility data suggest that it may be desirable to take the patient- and center-specific history of microorganisms and their sensitivity patterns into account when prescribing initial therapy. The vast majority of patients are treated successfully and continue peritoneal dialysis, with the poorest outcome noted in patients with peritonitis secondary to Gram-negative organisms or fungi and in those with a relapsing infection.

摘要

腹膜炎仍然是儿童腹膜透析的常见并发症,也是技术失败的最常见原因。微生物学的特点是革兰氏阳性菌占优势,真菌引起的腹膜炎不到 5%。国际儿科腹膜炎登记处收集的数据显示,腹膜炎的细菌病因以及无培养阳性腹膜炎的发生率在全球范围内存在差异。感染的危险因素包括年龄较小、导管放置时无预防性抗生素、透析袋尖峰、导管出口部位或隧道感染。临床表现的症状在某种程度上具有特定的病原体特征,可以通过疾病严重程度评分进行客观评估。虽然国际腹膜透析学会已经发布了儿童经验性抗生素治疗的建议,但流行病学数据和抗生素药敏数据表明,在开具初始治疗时,考虑患者和中心特定的微生物及其敏感模式可能是可取的。绝大多数患者治疗成功并继续腹膜透析,但革兰氏阴性菌或真菌引起的腹膜炎以及复发性感染患者的预后最差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a508/2810362/a267b3d0f2f5/467_2008_1113_Fig1_HTML.jpg

相似文献

1
Dialysis-associated peritonitis in children.
Pediatr Nephrol. 2010 Mar;25(3):425-40. doi: 10.1007/s00467-008-1113-6. Epub 2009 Feb 4.
3
Peritoneal Dialysis-Associated Peritonitis.
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1100-1105. doi: 10.2215/CJN.14631218. Epub 2019 May 8.
4
CAPD peritonitis. Incidence, pathogens, diagnosis, and management.
Med Clin North Am. 1990 Jul;74(4):997-1010. doi: 10.1016/s0025-7125(16)30532-6.
8
Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative.
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1590-1596. doi: 10.2215/CJN.02540316. Epub 2016 Jun 23.
9
Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.
Am J Kidney Dis. 2008 Mar;51(3):455-62. doi: 10.1053/j.ajkd.2007.11.011.
10
Continuous ambulatory peritoneal dialysis peritonitis: Microbiology and outcomes.
Indian J Med Microbiol. 2020 Jan-Mar;38(1):72-77. doi: 10.4103/ijmm.IJMM_20_251.

引用本文的文献

4
Assessment of potential peritonitis risk factors in pediatric patients receiving maintenance peritoneal dialysis.
Pediatr Nephrol. 2023 Dec;38(12):4119-4125. doi: 10.1007/s00467-023-06076-9. Epub 2023 Jul 8.
6
Postoperative management and complications after abdominal surgery in children receiving peritoneal dialysis.
Pediatr Nephrol. 2023 Oct;38(10):3427-3434. doi: 10.1007/s00467-023-06009-6. Epub 2023 May 6.
7
Chronic peritoneal dialysis in children with chronic kidney disease: An experience from a North Indian teaching institute.
J Family Med Prim Care. 2021 Oct;10(10):3682-3687. doi: 10.4103/jfmpc.jfmpc_250_21. Epub 2021 Nov 5.
9
Peritonitis in children on peritoneal dialysis: 12 years of tertiary center experience.
Int J Pediatr Adolesc Med. 2021 Dec;8(4):229-235. doi: 10.1016/j.ijpam.2020.09.001. Epub 2020 Sep 19.
10
Structured re-training to reduce peritonitis in a pediatric peritoneal dialysis program: a quality improvement intervention.
Pediatr Nephrol. 2021 Oct;36(10):3191-3200. doi: 10.1007/s00467-021-05039-2. Epub 2021 Apr 2.

本文引用的文献

1
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
Cochrane Database Syst Rev. 2017 Apr 8;4(4):CD004679. doi: 10.1002/14651858.CD004679.pub3.
2
Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children.
Pediatr Nephrol. 2010 Jan;25(1):75-81. doi: 10.1007/s00467-008-0982-z.
4
Encapsulating peritoneal sclerosis in Japan.
Perit Dial Int. 2008 Jun;28 Suppl 3:S201-4.
5
Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.
Am J Kidney Dis. 2008 Mar;51(3):455-62. doi: 10.1053/j.ajkd.2007.11.011.
6
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
Pediatr Infect Dis J. 2007 Oct;26(10):879-91. doi: 10.1097/INF.0b013e3180cbd382.
7
Worldwide variation of dialysis-associated peritonitis in children.
Kidney Int. 2007 Dec;72(11):1374-9. doi: 10.1038/sj.ki.5002523. Epub 2007 Sep 19.
8
Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines.
J Am Soc Nephrol. 2007 Jul;18(7):2172-9. doi: 10.1681/ASN.2006101158. Epub 2007 Jun 20.
9
Prevention of peritonitis in children receiving peritoneal dialysis.
Pediatr Nephrol. 2007 Apr;22(4):578-85. doi: 10.1007/s00467-006-0375-0. Epub 2007 Jan 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验